World Business Council for Sustainable Development (WBCSD) is collaborating with leading companies in the sector, with support from PwC UK, to develop a Roadmap to Nature Positive for the ...

GSK plc (NYSE:GSK – Get Free Report) was the target of some unusual options trading activity on Wednesday. Stock traders bought 25,931 call options on the stock. This is an increase of 446% compared ...

Haleon’s pilot run of the screener analyzed 1,500 pieces of creative for the Panadol pain relief brand across nine markets.

Ionis has five FDA-approved drugs and promising upcoming approvals. See more about IONS stock and why it warrants a Buy ...

Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.

Approval of Pfizer's Abrysvo in certain adults aged 18 to 59 years old will substantially expand the number of people ...

Pfizer's RSV vaccine Abrysvo receives FDA approval for adults 18-59 at high risk, with extended use for pregnant individuals ...

North Carolina is a leading place for biotech, and a big part of that success comes from GlaxoSmithKline (GSK). This global ...

Asthma affects approximately 262 million people globally, with the number of asthma incidents having increased by around 15% ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...